Phosphoramidite Market Size to Surpass USD 2.69 Billion by 2035 | SNS Insider
Austin, United States, Aug. 20, 2026 (GLOBE NEWSWIRE) -- The Phosphoramidite Market Size was valued at USD 1.27 Billion in 2025 and is projected to reach USD 2.69 Billion by 2035, growing at a CAGR of 7.78% during 2026–2035, according to a new report by SNS Insider. Expansion of the global market is fueled by the increasing demand for oligonucleotides therapies, RNA drugs, genetic engineering, and diagnostic applications.
The Phosphoramidite Market is gaining momentum as pharmaceutical and biotechnology companies expand the development of oligonucleotide therapeutics, CRISPR-based technologies, RNA vaccines, molecular diagnostics, and synthetic biology applications. Rising demand for high-purity nucleic acid building blocks, GMP-grade phosphoramidites, and custom-modified reagents is further increasing procurement across research, clinical development, and commercial manufacturing workflows.
Download the Phosphoramidite Market Sample Report: https://www.snsinsider.com/sample-request/8264
Key Takeaways:
Oligonucleotide Therapeutics Drive Phosphoramidite Market Growth
The market for Phosphoramidites is seeing constant growth due to the increasing use of nucleic acid synthesis technologies by drug manufacturers, biotechnology companies, diagnostic companies, and research centers. The rising development of therapeutic oligonucleotides, CRISPR genome editing, mRNA technology, molecular diagnostics, and synthetic biology is making the need for high purity phosphoramidites more prevalent. Increased spending in genomics research and increased demands for nucleic acid synthesis are further leading to investments in new generation synthesis systems and reagents.
Segmentation Analysis
DNA Phosphoramidites Lead the Market by Type
The DNA Phosphoramidites category accounted for 39.81% of the phosphoramidites market share in 2025 due to its widespread application in oligonucleotides, PCR primers, gene editing, and drug discovery applications. The RNA phosphoramidites category is anticipated to witness the highest growth rate during the forecast period of 2026-2035, growing at a CAGR of 8.64% driven by increasing applications in mRNA vaccines, siRNA therapeutics, and RNA-based diagnostics.
By Purity, GMP-Grade Phosphoramidites Record Strong Growth
Standard Research Grade occupied the maximum market share of around 38.73%, aided by the extensive application of the grade across academic institutions and laboratories, and the early adoption of the grade in biotechnological applications. GMP Grade will experience the highest compound annual growth rate (CAGR) of 8.51%, fueled by increasing therapeutics pipelines and regulatory compliance requirements.
By Application, Drug Discovery Leads Phosphoramidite Market
Drug Discovery and Development led the phosphoramidites market due to the application of phosphoramidites in therapeutic oligonucleotides, aptamers, antisense drugs, preclinical studies, and high throughput drug discovery. Diagnostics Development is expected to experience the highest growth of 8.30% CAGR since molecular diagnostics, qPCR, next-generation sequencing, probe-based assays, cancer biomarker detection, and genetic disorder diagnostics will keep growing.
By End User, Pharmaceutical and Biotechnology Companies Lead End-User Demand
The category of Pharmaceutical & Biotechnology Companies was the dominant end user sector owing to its significant participation in developing oligonucleotide drugs, mRNA vaccines, gene therapy, siRNA, ASO and CRISPR technologies. Academic & Research Institutions are experiencing the fastest growth rate due to the rising investments in genomics, synthetic biology, molecular diagnostics, and gene editing.
Regional Analysis:
The North American region held a share of about 40.60% in the phosphoramidites market of the world in 2025, which can be attributed to its advanced biotech ecosystem, high investment in R&D, and the presence of prominent companies, such as Thermo Fisher, TriLink, and IDT. High development of oligonucleotide drugs, CRISPR, and mRNA therapy is driving the demand for GMP phosphoramidites and custom phosphoramidites.
The U.S. Phosphoramidite Market was valued at USD 401.62 Million in 2025 and is expected to reach USD 837.82 Million by 2035, expanding at a CAGR of 7.63% during 2026–2035. The U.S. markets have several advantages owing to its robust base in pharmaceutical R&D, market players, high demand for oligonucleotide drugs, and development in the areas of mRNA, CRISPR, and synthetic biology. Favorable government regulations and rising manufacturing capabilities enhance the dominance of the country in the phosphoramidites market.
Europe Phosphoramidite Market was valued at USD 380 Million in 2025 and is expected to reach USD 790 Million by 2035, expanding at a CAGR of 7.50% during 2026–2035. The European region holds the second largest share in the phosphoramidites market owing to the presence of well-established infrastructure in the pharma and biotech sector, key contract manufacturing organizations (CMOs), advanced research institutions, and developments of oligonucleotides drugs.
Asia Pacific is expected to be the fastest-growing regional market with an 8.47% CAGR, due to the rapid developments in biotechnology, investments by governments, rising production capacity of drugs, and investments in the field of genomics and synthetic biology. The countries that are helping the region grow include China, India, South Korea, and Japan.
Explore the Complete Phosphoramidite Market Report: https://www.snsinsider.com/reports/phosphoramidite-market-8264
Leading Market Players Listed in this Report are:
Recent Developments:
Exclusive Sections of the Report (The USPs)
Buy the Phosphoramidite Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/8264
Phosphoramidite Market Report Scope
Related Market Reports
Oligonucleotide Synthesis Market Size 2026
DNA Synthesis Market Growth 2026
DNA Synthesizer Market Trends 2026
Nucleotide Market Outlook 2026
Gene Synthesis Market Size 2026
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.